©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 114286
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114286
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114286
Figure 6 Comparison the sensitivity of patient-derived tumor-like cell clusters to different drug regimens within individuals.
A: Sensitivity of colorectal cancer (CRC)-10, CRC-32 and CRC-43 to FOLFOX and FOXFIRI; B: Sensitivity of CRC-02, CRC-35 and CRC-10 to FOLFOX, FOXFIRI and FOLFOXIRI. aP < 0.05, cP < 0.001. CRC: Colorectal cancer.
- Citation: Lin FL, Zhou LM, Ye YJ, Luo XL, Ji XL, Chen SQ, Xie JG, Jin BF, Liu ZD. Individual chemotherapy for patients colorectal cancer based on patient-derived tumor-like cell clusters. World J Gastrointest Surg 2026; 18(2): 114286
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/114286.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.114286